Ibovespa rises with attention to the US elections; dollar falls to R $ 5.57



[ad_1]

stock market stock market stock indices charts

(Shutterstock)

SÃO PAULO – The Ibovespa rises on Thursday (5) with investors still waiting for the end of the count in the US elections. Democrat Joe Biden, with 264 delegates to his opponent’s 214, only needs to win one more state to be elected, but his lead over incumbent President Donald Trump in Nevada fell to 6,000 votes.

Today, the markets will continue to pay attention to the decision of the Federal Open Market Committee (Fomc). A change in interest rates is not expected amid the US electoral dispute, but it will be important to follow the speech of the Chairman of the Federal Reserve, Jerome Powell.

At 10:11 am (Brasilia time), the Ibovespa rose 1.66% to 99,490 points.

Meanwhile, the commercial dollar fell 0.93% to R $ 5,577 in the purchase and R $ 5,578 in the sale. The future dollar due in December registered a decrease of 1.67%, to R $ 5,561.

In the future interest market, the ID of January 2022 falls seven basis points to 3.39%, the ID of January 2023 falls seven basis points to 4.99%, the ID of January 2025 falls by eight basis points at 6.68 % and the DI of January 2027 registered a negative variation of seven basis points at 7.47%.

Returning to the United States, the market also follows the composition of the American Congress. As of Wednesday night, Democrats appeared to be in the process of taking control of the House of Representatives, while Republicans appeared to maintain control over the Senate. As of Thursday morning, Republican control still does not appear assured, but there does not appear to be democratic supremacy either.

Senators are responsible for confirming the names designated by the president for important positions and can push or prohibit measures of interest to the White House.

The prospect of a congress divided between Democrats and Republicans is viewed favorably by several investors, fearing that too strong a Democratic government will lead to over-regulation, especially at big tech companies.

Today in Europe, the United Kingdom begins its new one-month confinement this Thursday. And the Bank of England raised its QE program by £ 150bn as it expects the British economy to contract in the fourth quarter.

It should also be noted that, in a report, the European Commission predicted that the Gross Domestic Product (GDP) of the 19 countries that make up the euro zone will suffer a drop of 7.8% in 2020, less than the estimated drop of 8.7 %. in July. By 2021, however, the block’s GDP advance projection decreased from 6.1% to 4.2%. By 2022, the estimate increases by 3%. A second wave of the new coronavirus pandemic is jeopardizing hopes that the eurozone economy will recover quickly.

Follow the exemption

In July 2020, Bolsonaro had vetoed a congressional provision that extended until the end of 2021 the payroll exemption for companies in 17 sectors, responsible for employing a large contingent of people, including call centers, transportation, civil construction, industry. textile and communications.

On Wednesday, the Senate and House overturned the veto, keeping the benefit. The exemption allows companies to contribute between 1% and 4.5% of their gross income to Social Security, instead of collecting 20% ​​in payroll. Thus, layoffs are avoided in these 17 sectors, responsible for employing around 6 million people in Brazil.

On the other hand, a meeting of the Deliberative Council of the FAT (Workers’ Support Fund) decided not to extend unemployment insurance in two more installments to people laid off in the period between March 20 and July 31, which that would benefit 2.7 million workers.

The extension was proposed by the unions and was defeated in an alliance between government representatives and businessmen on the FAT council, by 12 votes to 6.

Vaccination in Brazil

The British pharmaceutical AstraZeneca announced this Thursday together with its quarterly balance that it hopes to present data on the coronavirus vaccine that it has been developing in partnership with the University of Oxford later this year. These vaccines are being tested in Brazil and should be part of the country’s strategy to combat covid.

“Results of late-stage trials should be anticipated this year, depending on the infection rate in the communities where clinical trials are being conducted. The data will be sent to regulators and published in scientific journals, ”AstraZeneca said in its results.

On the quarterly balance sheet, AstraZeneca noted that global product sales increased 7% to US $ 6.52 billion in the third quarter, above market expectation of US $ 6.5 billion.

The company should produce vaccines in Brazil in partnership with Fiocruz. In a ceremony held on Wednesday, the director of Bio-Manguinhos / Fiocruz, Maurício Zuma, said that the institution intends to start production as soon as it receives the active pharmaceutical ingredient, even before the approval of Anvisa. He expects to receive the ingredient in January, start production, and have up to 30 million doses as early as February.

Rosane Cuber, deputy director of quality at Bio-Manguinhos / Fiocruz said that the vaccine showed good results, with the development of neutralizing antibodies against Sars-Cov-2 in 91% of the volunteers who participated in the tests.

In addition, in a position sent to the Supreme Federal Court this Wednesday, President Jair Bolsonaro (without a party) stated that he “does not see a different treatment” with respect to the product being developed by the Chinese Sinovac, which should be produced in Brazil by the Institute. Butantan. But he said the government’s “political will” regarding the purchase of covid-19 vaccines must be respected.

The document was sent in response to two allegations of non-compliance with a fundamental precept filed in court by opposition parties, given the fact that, in October, the president dismissed the Minister of Health, Eduardo Pazuello, who announced his intention to buy 64 million doses of the vaccine produced by Butantan.

“Once a vaccine has passed all stages of development and is registered with Anvisa, it will be evaluated by the Ministry of Health and will be available to the population through the national immunization program,” says the document.

Corporate radar

Once again, the corporate news highlights the earnings season, with an emphasis on the results of Banco do Brasil, as well as d1000, Banco Pan, Ultrapar, São Carlos, BR Properties, Cia. Hering, Ecorodovias and Mercado Livre.

Banco do Brasil had an adjusted net income of R $ 3,482 billion in the third quarter, a drop of 23.3% compared to the same period of 2019, but an increase of 5.2% compared to the second quarter of 2020.

Cia Hering had a jump in net profit in the third quarter, which was R $ 155.5 million, more than double the same period last year. Performance was based on accounting for tax credits.

Ultrapar had results above the analysts’ projection in the third quarter, with a profit in the third quarter of R $ 277.3 million, 9.76% less than in the same period of the previous year. The expectation of the analysts heard by Refinitiv was R $ 272.7 million.

Ecorodovias announced a profit of R $ 71.6 million in the third quarter, below Refinitiv’s expectation of R $ 75.1 million.

The Mercado Libre reported a sales volume of US $ 5.9 billion in the third quarter, an increase of 62.1%. Mercado Pago had a 91.7% increase in the volume of payments.

Do you know what 3 × 1 is? See the options strategy that seeks to triple the capital invested in a free month



[ad_2]